APA (7th ed.) Citation

Liu, H., Ertay, A., Peng, P., Li, J., Liu, D., Xiong, H., . . . Wang, Y. (2019). SGLT1 is required for the survival of triple‐negative breast cancer cells via potentiation of EGFR activity. Molecular oncology, 13(9), 1874-1886. https://doi.org/10.1002/1878-0261.12530

Chicago Style (17th ed.) Citation

Liu, Huiquan, et al. "SGLT1 Is Required for the Survival of Triple‐negative Breast Cancer Cells via Potentiation of EGFR Activity." Molecular Oncology 13, no. 9 (2019): 1874-1886. https://doi.org/10.1002/1878-0261.12530.

MLA (9th ed.) Citation

Liu, Huiquan, et al. "SGLT1 Is Required for the Survival of Triple‐negative Breast Cancer Cells via Potentiation of EGFR Activity." Molecular Oncology, vol. 13, no. 9, 2019, pp. 1874-1886, https://doi.org/10.1002/1878-0261.12530.